ArticleOne health outlook2026
Infection of urban rodents by SARS-CoV-2 in COVID-19 healthcare facilities in Brazzaville, Republic of the Congo.
Article in One health outlook, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConsidering the global increase of COVID-19 cases in the healthcare facilities between 2020 and 2021, and the widespread presence of pest rodents in Brazzaville, we conducted this study at the end of the pandemic peak to assess the potential for urban rodents to be infected with SARS-CoV-2 in the Republic of the Congo.
methodsBetween April and December 2022, a total of 96 rodent were captured in three COVID-19 healthcare facilities in Brazzaville. Intestinal samples were tested for SARS-CoV-2 RNA using RT-qPCR, followed by nested RT-PCR targeting the RdRp gene and Sanger sequencing. Concurrently, serum samples were analysed to detect SARS-CoV-2 antibodies using the Luminex technology.
resultsSARS-CoV-2 RNA was detected in intestinal samples from nine (9.4%) rodent: 7/80 (8.7%) R. rattus, 1/13 (7.7%) R. tanezumi, and 1/2 (50%) M. musculus. Phylogenetic analyses using Nextclade and maximum likelihood phylogeny methods revealed substantial diversity among SARS-CoV-2 partial genome belonging to clades 20B, 20G, Recombinant, 21 K and 22B. Additionally, 9/96 (9.4%) rodents tested seropositive for SARS-CoV-2 antibodies.
conclusionsThese findings provide evidence for the establishment of new SARS-CoV-2 reservoirs in certain animal populations, emphasizing the urgent need for continuous surveillance to prevent future outbreaks from animal sources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.